Neurodegenerative diseases / hypoxia

Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

TECHNICAL FIELD OF THE INVENTION This invention relates to pharmaceutical compositions useful for treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration, and to methods for using the compositions. BACKGROUND OF THE INVENTION Neurotrophic factors exhibit a trophic effect

Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to methods for preconditioning and/or providing neuroprotection to the animal central nervous system against ischemia, neurodegeneration, trauma and metal poisoning, including associated cognitive, behavioral and

Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

The invention relates to the use of triazolones as pharmaceutical compositions, particularly pharmaceutical compositions with a neuroprotective activity, as well as new triazolones and processes for preparing them. Triazolones are known from the prior art and are disclosed, for example, by published

Compositions and methods for treating cancer and neurodegenerative diseases

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION The present invention relates to compositions and methods for regulating death-associated protein kinase (DAPk) activity. The compositions and methods of the present invention are useful for treating or ameliorating cancer as well as pathologies associated with neuronal cell

Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION The present invention pertains to improved methods for using selegiline in therapeutic applications. In particular, the invention is directed to improved methods for treating certain selegiline-responsive diseases and conditions by administering selegiline either buccally or

Oligonucleotides which inhibit p53 induction in response to cellular stress

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION The present invention relates to modulating the activity of p53 tumor suppressor protein by affecting p53 translational regulation and its use for minimizing the negative effects of cellular stresses. More specifically, the invention relates to novel oligonucleotides which

Use of pyruvate to prevent neuronal degeneration associated with ischemia

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

BACKGROUND OF THE INVENTION The invention is in the fields of neurology and pharmacology and relates to protecting the brain and central nervous system against damage due to ischemia and other neurological disorders in which energy-providing substrates (oxygen and glucose) are reduced or energy

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention is in the field of medicinal chemistry. In particular, this invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical composition comprising the same, which possess neuroprotective capability. This invention further relates

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

BACKGROUND OF THE INVENTION This invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods for treating any disease of the nervous system in

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention is in the field of medicinal chemistry. In particular, this invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical composition comprising the same, which possess neuroprotective capability. This invention further relates

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

neurodegenerative diseases/hypoxia

Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration

Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia

Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones

Compositions and methods for treating cancer and neurodegenerative diseases

Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions

Oligonucleotides which inhibit p53 induction in response to cellular stress

Use of pyruvate to prevent neuronal degeneration associated with ischemia

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Nejúplnější databáze léčivých bylin podložená vědou